ACADIA PHARMACEUTICALS INC. Net Income
ACADIA PHARMACEUTICALS INC. (ACAD) reported Net Income of $31.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-05
- ACADIA PHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was $31.50M, a 18.13% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was $3.64M, a 80.84% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was $273.57M, a 90.92% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was $71.78M, a 119.07% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2020 was -$281.58M.
- ACADIA PHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2019 was -$235.26M.
- ACADIA PHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2018 was -$245.19M.
- ACADIA PHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2017 was -$289.40M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $31.50M 10-Q · filed 2026-08-05 | $35.14M 10-Q · filed 2026-08-05 | $308.70M derived: sum of 3 quarters · filed 2026-08-05 | $380.48M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $3.64M 10-Q · filed 2026-05-07 | $277.20M derived: sum of 2 quarters · filed 2026-05-07 | $348.98M derived: sum of 3 quarters · filed 2026-05-07 | $375.65M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $273.57M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-24 | $345.35M derived: sum of 2 quarters · filed 2026-04-24 | $372.01M derived: sum of 3 quarters · filed 2026-08-05 | $391.00M DEF 14A · filed 2026-04-24 | |
| 2025-09-30 | $71.78M 10-Q · filed 2025-11-06 | $98.44M derived: sum of 2 quarters · filed 2026-08-05 | $117.43M 10-Q · filed 2025-11-06 | $260.72M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $26.67M 10-Q · filed 2026-08-05 | $45.65M 10-Q · filed 2026-08-05 | $188.94M derived: sum of 3 quarters · filed 2026-08-05 | $221.71M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $18.99M 10-Q · filed 2026-05-07 | $162.28M derived: sum of 2 quarters · filed 2026-05-07 | $195.04M derived: sum of 3 quarters · filed 2026-05-07 | $228.43M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $143.29M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-24 | $176.06M derived: sum of 2 quarters · filed 2026-04-24 | $209.44M derived: sum of 3 quarters · filed 2026-04-24 | $226.00M DEF 14A · filed 2026-04-24 | $226.45M 10-K · filed 2025-02-27 |
| 2024-09-30 | $32.77M 10-Q · filed 2025-11-06 | $66.15M derived: sum of 2 quarters · filed 2025-11-06 | $82.71M 10-Q · filed 2025-11-06 | $128.51M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $33.39M 10-Q · filed 2025-08-07 | $49.94M 10-Q · filed 2025-08-07 | $95.74M derived: sum of 3 quarters · filed 2025-08-07 | $30.57M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $16.55M 10-Q · filed 2025-05-08 | $62.35M derived: sum of 2 quarters · filed 2025-05-08 | -$2.82M derived: sum of 3 quarters · filed 2025-05-08 | -$1.71M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $45.80M 10-K · filed 2024-02-28 | -$19.38M derived: sum of 2 quarters · filed 2024-11-07 | -$18.27M derived: sum of 3 quarters · filed 2024-11-07 | -$61.00M DEF 14A · filed 2026-04-24 | -$61.29M 10-K · filed 2024-02-28 |
| 2023-09-30 | -$65.18M 10-Q · filed 2024-11-07 | -$64.06M derived: sum of 2 quarters · filed 2024-11-07 | -$107.08M 10-Q · filed 2024-11-07 | -$148.81M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $1.11M 10-Q · filed 2024-08-07 | -$41.91M 10-Q · filed 2024-08-07 | -$83.63M derived: sum of 3 quarters · filed 2024-08-07 | -$110.81M derived: sum of 4 quarters · filed 2024-08-07 | |
| 2023-03-31 | -$43.02M 10-Q · filed 2024-05-09 | -$84.75M derived: sum of 2 quarters · filed 2024-05-09 | -$111.93M derived: sum of 3 quarters · filed 2024-05-09 | -$145.94M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$41.73M 10-K · filed 2024-02-28 | -$68.91M derived: sum of 2 quarters · filed 2024-02-28 | -$102.92M derived: sum of 3 quarters · filed 2024-02-28 | -$214.00M DEF 14A · filed 2026-04-24 | -$215.97M 10-K · filed 2023-02-28 |
| 2022-09-30 | -$27.18M 10-K · filed 2024-02-28 | -$61.19M derived: sum of 2 quarters · filed 2024-02-28 | -$174.25M 10-Q · filed 2023-11-03 | -$217.34M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | -$34.01M 10-K · filed 2024-02-28 | -$147.07M 10-Q · filed 2023-08-03 | -$190.16M derived: sum of 3 quarters · filed 2024-02-28 | -$204.62M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | -$113.06M 10-K · filed 2024-02-28 | -$156.15M derived: sum of 2 quarters · filed 2024-02-28 | -$170.61M derived: sum of 3 quarters · filed 2024-02-28 | -$214.48M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | -$43.09M 10-K · filed 2023-02-28 | -$57.55M derived: sum of 2 quarters · filed 2023-02-28 | -$101.42M derived: sum of 3 quarters · filed 2023-02-28 | -$168.00M DEF 14A · filed 2026-04-24 | -$167.87M 10-K · filed 2022-03-01 |
| 2021-09-30 | -$14.46M 10-K · filed 2023-02-28 | -$58.33M derived: sum of 2 quarters · filed 2023-02-28 | -$124.78M 10-Q · filed 2022-11-03 | -$191.54M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | -$43.87M 10-K · filed 2023-02-28 | -$110.32M 10-Q · filed 2022-08-09 | -$177.08M derived: sum of 3 quarters · filed 2023-02-28 | ||
| 2021-03-31 | -$66.45M 10-K · filed 2023-02-28 | -$133.21M derived: sum of 2 quarters · filed 2023-02-28 | |||
| 2020-12-31 | -$66.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$281.58M 10-K · filed 2023-02-28 | |||
| 2020-12-30 | -$66.76M 10-K · filed 2022-03-01 | -$151.42M derived: sum of 2 quarters · filed 2022-03-01 | -$193.56M derived: sum of 3 quarters · filed 2022-03-01 | -$281.58M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-09-30 | -$84.66M 10-K · filed 2022-03-01 | -$126.80M derived: sum of 2 quarters · filed 2022-03-01 | -$214.82M 10-Q · filed 2021-11-09 | -$267.86M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | -$42.14M 10-K · filed 2022-03-01 | -$130.16M 10-Q · filed 2021-08-05 | -$183.20M derived: sum of 3 quarters · filed 2022-03-01 | -$225.18M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$88.02M 10-K · filed 2022-03-01 | -$141.06M derived: sum of 2 quarters · filed 2022-03-01 | -$183.04M derived: sum of 3 quarters · filed 2022-03-01 | -$237.98M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$53.04M 10-K · filed 2021-02-25 | -$95.01M derived: sum of 2 quarters · filed 2021-02-25 | -$149.96M derived: sum of 3 quarters · filed 2021-02-25 | -$235.26M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$41.98M 10-K · filed 2021-02-25 | -$96.92M derived: sum of 2 quarters · filed 2021-02-25 | -$182.22M 10-Q · filed 2020-11-04 | -$247.72M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | -$54.94M 10-K · filed 2021-02-25 | -$140.25M 10-Q · filed 2020-08-06 | -$205.74M derived: sum of 3 quarters · filed 2021-02-25 | -$267.88M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | -$85.30M 10-K · filed 2021-02-25 | -$150.80M derived: sum of 2 quarters · filed 2021-02-25 | -$212.93M derived: sum of 3 quarters · filed 2021-02-25 | -$276.20M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$65.49M 10-K · filed 2020-02-27 | -$127.63M derived: sum of 2 quarters · filed 2020-02-27 | -$190.90M derived: sum of 3 quarters · filed 2020-02-27 | -$245.19M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$62.14M 10-K · filed 2020-02-27 | -$125.40M derived: sum of 2 quarters · filed 2020-02-27 | -$179.70M 10-Q · filed 2019-10-31 | -$248.57M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | -$63.27M 10-K · filed 2020-02-27 | -$117.56M 10-Q · filed 2019-08-01 | -$186.43M derived: sum of 3 quarters · filed 2020-02-27 | -$251.68M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$54.30M 10-K · filed 2020-02-27 | -$123.17M derived: sum of 2 quarters · filed 2020-02-27 | -$188.41M derived: sum of 3 quarters · filed 2020-02-27 | -$255.86M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$68.87M 10-K · filed 2019-02-27 | -$134.12M derived: sum of 2 quarters · filed 2019-02-27 | -$201.56M derived: sum of 3 quarters · filed 2019-02-27 | -$289.40M 10-K · filed 2020-02-27 | |
| 2017-09-30 | -$65.25M 10-K · filed 2019-02-27 | -$132.69M derived: sum of 2 quarters · filed 2019-02-27 | -$220.53M 10-Q · filed 2018-11-06 | -$299.23M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | -$67.44M 10-K · filed 2019-02-27 | -$155.28M 10-Q · filed 2018-08-08 | -$233.98M derived: sum of 3 quarters · filed 2019-02-27 | -$305.59M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | -$87.84M 10-K · filed 2019-02-27 | -$166.54M derived: sum of 2 quarters · filed 2019-02-27 | -$238.15M derived: sum of 3 quarters · filed 2019-02-27 | -$309.47M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | -$78.70M 10-K · filed 2018-02-27 | -$150.31M derived: sum of 2 quarters · filed 2018-02-27 | -$221.63M derived: sum of 3 quarters · filed 2018-02-27 | -$271.39M 10-K · filed 2019-02-27 | |
| 2016-09-30 | -$71.61M 10-K · filed 2018-02-27 | -$142.94M derived: sum of 2 quarters · filed 2018-02-27 | -$192.70M 10-Q · filed 2017-11-07 | -$238.48M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | -$71.32M 10-K · filed 2018-02-27 | -$121.08M 10-Q · filed 2017-08-08 | -$166.87M derived: sum of 3 quarters · filed 2018-02-27 | -$205.77M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | -$49.76M 10-K · filed 2018-02-27 | -$95.55M derived: sum of 2 quarters · filed 2018-02-27 | -$134.45M derived: sum of 3 quarters · filed 2018-02-27 | -$173.83M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | -$45.78M 10-K · filed 2017-02-28 | -$84.69M derived: sum of 2 quarters · filed 2017-02-28 | -$124.07M derived: sum of 3 quarters · filed 2017-02-28 | -$164.44M 10-K · filed 2018-02-27 | |
| 2015-09-30 | -$38.91M 10-K · filed 2017-02-28 | -$78.28M derived: sum of 2 quarters · filed 2017-02-28 | -$118.66M 10-Q · filed 2016-11-07 | -$147.03M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-06-30 | -$39.38M 10-K · filed 2017-02-28 | -$79.75M 10-Q · filed 2016-08-04 | -$108.12M derived: sum of 3 quarters · filed 2017-02-28 | -$132.91M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-03-31 | -$40.38M 10-K · filed 2017-02-28 | -$68.74M derived: sum of 2 quarters · filed 2017-02-28 | -$93.53M derived: sum of 3 quarters · filed 2017-02-28 | -$115.02M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2014-12-31 | -$28.37M 10-K · filed 2016-02-29 | -$53.15M derived: sum of 2 quarters · filed 2016-02-29 | -$74.65M derived: sum of 3 quarters · filed 2016-02-29 | -$92.47M 10-K · filed 2017-02-28 | |
| 2014-09-30 | -$24.79M 10-K · filed 2016-02-29 | -$46.28M derived: sum of 2 quarters · filed 2016-02-29 | -$64.11M 10-Q · filed 2015-11-05 | -$76.16M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$21.50M 10-K · filed 2016-02-29 | -$39.32M 10-Q · filed 2015-08-06 | -$51.37M derived: sum of 3 quarters · filed 2016-02-29 | -$62.07M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | -$17.83M 10-K · filed 2016-02-29 | -$29.88M derived: sum of 2 quarters · filed 2016-02-29 | -$40.57M derived: sum of 3 quarters · filed 2016-02-29 | -$49.65M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$12.05M 10-K · filed 2015-02-26 | -$22.74M derived: sum of 2 quarters · filed 2015-02-26 | -$31.82M derived: sum of 3 quarters · filed 2015-02-26 | -$37.95M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$10.70M 10-K · filed 2015-02-26 | -$19.78M derived: sum of 2 quarters · filed 2015-02-26 | -$25.90M 10-Q · filed 2014-11-10 | -$32.71M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-06-30 | -$9.08M 10-K · filed 2015-02-26 | -$15.20M 10-Q · filed 2014-08-05 | -$22.01M derived: sum of 3 quarters · filed 2015-02-26 | -$24.42M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-03-31 | -$6.12M 10-K · filed 2015-02-26 | -$12.93M derived: sum of 2 quarters · filed 2015-02-26 | -$15.34M derived: sum of 3 quarters · filed 2015-02-26 | -$20.75M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2012-12-31 | -$6.81M 10-K · filed 2014-02-27 | -$9.21M derived: sum of 2 quarters · filed 2014-02-27 | -$14.63M derived: sum of 3 quarters · filed 2014-02-27 | -$20.85M 10-K · filed 2015-02-26 | |
| 2012-09-30 | -$2.40M 10-K · filed 2014-02-27 | -$7.82M derived: sum of 2 quarters · filed 2014-02-27 | -$14.04M 10-Q · filed 2013-11-06 | -$19.34M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2012-06-30 | -$5.42M 10-K · filed 2014-02-27 | -$11.64M 10-Q · filed 2013-08-06 | -$16.94M derived: sum of 3 quarters · filed 2014-02-27 | -$22.01M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2012-03-31 | -$6.22M 10-K · filed 2014-02-27 | -$11.52M derived: sum of 2 quarters · filed 2014-02-27 | -$16.59M derived: sum of 3 quarters · filed 2014-02-27 | -$23.15M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2011-12-31 | -$5.30M 10-K · filed 2013-03-12 | -$10.38M derived: sum of 2 quarters · filed 2013-03-12 | -$16.93M derived: sum of 3 quarters · filed 2013-03-12 | -$22.77M 10-K · filed 2014-02-27 | |
| 2011-09-30 | -$5.08M 10-K · filed 2013-03-12 | -$11.63M derived: sum of 2 quarters · filed 2013-03-12 | -$17.46M 10-Q · filed 2012-11-05 | $11.68M derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-06-30 | -$6.56M 10-K · filed 2013-03-12 | -$12.39M 10-Q · filed 2012-08-08 | $16.75M derived: sum of 3 quarters · filed 2013-03-12 | $12.53M derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-03-31 | -$5.83M 10-K · filed 2013-03-12 | $23.31M derived: sum of 2 quarters · filed 2013-03-12 | $19.08M derived: sum of 3 quarters · filed 2013-03-12 | $14.79M derived: sum of 4 quarters · filed 2013-03-12 | |
| 2010-12-31 | $29.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $24.91M derived: sum of 2 quarters · filed 2013-03-12 | $20.63M derived: sum of 3 quarters · filed 2013-03-12 | $15.14M 10-K · filed 2013-03-12 | |
| 2010-09-30 | -$4.23M 10-Q · filed 2011-11-09 | -$8.52M derived: sum of 2 quarters · filed 2011-11-09 | -$14.00M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$4.29M 10-Q · filed 2011-08-10 | -$9.78M 10-Q · filed 2011-08-10 | |||
| 2009-12-31 | -$45.15M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |